An interfacial self-assembling bioink for the manufacturing of capillary-like structures with tuneable and anisotropic permeability by Wu, Yuanhao et al.
Biofabrication
     
PAPER • OPEN ACCESS
An interfacial self-assembling bioink for the manufacturing of capillary-
like structures with tuneable and anisotropic permeability
To cite this article: Yuanhao Wu et al 2021 Biofabrication 13 035027
 
View the article online for updates and enhancements.
This content was downloaded from IP address 80.2.41.206 on 26/04/2021 at 13:32












this work may be used




of this work must
maintain attribution to
the author(s) and the title
of the work, journal
citation and DOI.
PAPER
An interfacial self-assembling bioink for the manufacturing
of capillary-like structures with tuneable and anisotropic
permeability
Yuanhao Wu1,2,3,4, Gabriele Maria Fortunato5, Babatunde O Okesola3,4,
Francesco Luigi Pellerej Di Brocchetti5, Ratima Suntornnond6, John Connelly6, Carmelo De Maria5,
Jose Carlos Rodriguez-Cabello7, Giovanni Vozzi5, WenWang3,4 and Alvaro Mata1,2,3,4,8
1 School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, United Kingdom
2 Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, United Kingdom
3 Institute of Bioengineering, Queen Mary University of London, London E1 4NS, United Kingdom
4 School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, United Kingdom
5 Research Center ‘E. Piaggio’ andDipartimento di Ingegneria dell’Informazione, University of Pisa, Largo Lucio Lazzarino, Pisa 1-56122,
Italy
6 CREATE LAB, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London
E1 2AT, United Kingdom
7 BIOFORGE Group, University of Valladolid, CIBER-BBN, Valladolid 47011, Spain
8 Department of Chemical and Environmental Engineering, University of Nottingham, Nottingham NG7 2RD, United Kingdom
E-mail: a.mata@nottingham.ac.uk
Keywords: self-assembling bioink, hierarchical control, 3D printing, tuneable permeability, anisotropic structure
Supplementary material for this article is available online
Abstract
Self-assembling bioinks offer the possibility to biofabricate with molecular precision, hierarchical
control, and biofunctionality. For this to become a reality with widespread impact, it is essential to
engineer these ink systems ensuring reproducibility and providing suitable standardization. We
have reported a self-assembling bioink based on disorder-to-order transitions of an elastin-like
recombinamer (ELR) to co-assemble with graphene oxide (GO). Here, we establish reproducible
processes, optimize printing parameters for its use as a bioink, describe new advantages that the
self-assembling bioink can provide, and demonstrate how to fabricate novel structures with
physiological relevance. We fabricate capillary-like structures with resolutions down to∼10 µm in
diameter and∼2 µm thick tube walls and use both experimental and finite element analysis to
characterize the printing conditions, underlying interfacial diffusion-reaction mechanism of
assembly, printing fidelity, and material porosity and permeability. We demonstrate the capacity to
modulate the pore size and tune the permeability of the resulting structures with and without
human umbilical vascular endothelial cells. Finally, the potential of the ELR-GO bioink to enable
supramolecular fabrication of biomimetic structures was demonstrated by printing tubes
exhibiting walls with progressively different structure and permeability.
1. Introduction
Bioinks are increasingly playing a leading role in
the quest for recreating the structures and func-
tions of biological systems [1]. These materials are
being engineered to push biofabrication boundar-
ies such as the development of thick vascularized
structures [2], precise complex geometries [3], or
multicellular environments [4]. However, in spite of
these advances, important challenges remain such
as the capacity to replicate the molecular diversity,
structural hierarchy from the nano- to the macro-
scale, physiological biomechanical properties, and
ultimate functionality of the extracellular matrix
(ECM) [5] and corresponding tissues [6, 7]. Con-
sequently, it is essential to develop innovative bioinks
based on molecular and nanoscale building blocks
capable of organizing hierarchically [8] and enabling
communication between cellular and extracellular
components [9].
© 2021 The Author(s). Published by IOP Publishing Ltd
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Nature has evolved to grow and regenerate tis-
sues and organs by organizing, from the bottom-
up, multiple types of molecular components such as
proteins, lipids, and carbohydrates [10]. Inspired by
this, multicomponent self-assembly is being explored
to grow materials with multiple types of molecular
building-blocks exhibiting enhanced structural com-
plexity and functionality [11]. These materials offer
a unique opportunity to recreate chemical [12, 13]
and mechanical features [14, 15] of the ECM and
selectively communicate with cells [16]. The capa-
city to develop bioinks exhibiting such properties is
an exciting possibility to immediately present cells
[17] with complex, yet rationally designed, ECM-like
milieus [18] and signals at cellular and multicellular
levels [19]. Pioneering studies based on for example
self-assembling peptides [17, 20, 21] or nanoparticle/
polysaccharide co-assemblies [22] are demonstrating
this possibility. However, the widespread use of self-
assembly in additive manufacturing has been limited
in large part because of inadequate standardization
ensuring sufficient structural integrity, fast enough
speed of setting, and scalable manufacturing [23].
Liquid-in-liquid printing, the inoculation of one
low viscosity liquid phase into another [24], offers an
opportunity to design bioink materials that integrate
the benefits of multicomponent self-assembly with
additive manufacturing in a rationally designedman-
ner. For example, taking advantage of the interface
between oil and water, nanoclay-polymer surfact-
ants have been self-assembled into semi-permeable
membranes and perfusable capillaries [24]. Also,
printing a dextran water solution into a polyethyl-
ene oxide water solution enabled rapid fabrication
of biocompatible tissue-like 3D architectures such
as capillary networks and cardiac structures [25].
Furthermore, while traditional extrusion-based 3D
printing is defined by the printing nozzle dimension,
bioinks for liquid-in-liquid printing can be used to
immediately set and generate structures upon liquid
mixing [26], from the bottom-up, facilitating fab-
rication of high resolution structures. In addition,
liquid-in-liquid bioinks can also be used to trigger
emerging phenomena such as compartmentalization
[27] and diffusion-reaction processes [28], which are
used by biological systems such as cells and organelles
to regulate molecular transport and assembly into
functional higher-order structures. Taking advant-
ages of these opportunities, we have recently repor-
ted on a multicomponent self-assembly mechan-
ism harnessing disorder-to-order transitions of an
elastin-like recombinamer (ELR) to non-covalently
co-assemble with graphene oxide (GO) [29]. We
have demonstrated the possibility to use this sys-
tem in liquid-in-liquid bioprinting to enable fab-
rication of perfusable fluidic devices. However, it is
essential to optimize printing parameters and estab-
lish reproducible processes that can demonstrate
its use as a functional bioink and its advantages
to fabricate physiologically-relevant functional
structures.
In this study, we perform thorough
top-down/bottom-up standardization of our
ELR (ELK1)-GO co-assembling system to serve as a
liquid-in-liquid bioink and expand on its capabilities
for the fabrication (figure 1(a)) of functional capillar-
ies down to∼10µm in luminal diameter (figures 1(c)
and (e)) and ∼2 µm in wall thickness (figure 1(d)).
Through experimental and cross-platform finite ele-
ment analysis (COMSOL MultiPhysics® v5.5, COM-
SOL Group, Sweden), we demonstrate how these
perfusable structures exhibit a spectrum of structural
and biofunctional properties that are not possible for
most bioinks including sub 10 µm size features, the
capacity to pulsate, tuneable permeability with and




Rhodamine B (⩾95%, HPLC grade) and paraformal-
dehyde (95%) were obtained from Sigma-Aldrich (St.
Louis, Germany). GO (product number 777676) was
obtained from Sigma-Aldrich. Alexa Fluor™ 488NHS
Ester (product number A20000) was obtained from
Thermo Fisher Scientific (Waltham, USA). FITC-
dextran 40 kDa (product number FD40), 20 kDa
(product number FD20s), and fluorescein sodium
salt (product number 518-47-8) were obtained from
Sigma-Aldrich.
2.2. Synthesis and characterization of ELRs
ELR [ELK1: MESLLP-(VPGIG VPGIG VPGKG
VPGIG VPGIG)24] molecule was provided by TP
Nanobiotechnology (Valladolid, Spain), synthesised
and purified by Escherichia coli recombinant expres-
sion system. The sequence and molecular weights
of the polymers were verified using amino acid ana-
lysis. SDS-PAGE and MALDI-TOF SIMS were used
to carry out the ELK1 characterisation.
2.3. Sample preparation (ELK1-GO system)
Aqueous suspension of GO (0.1 wt%, 100 µl) was
added to a well of 96-well TCP and aqueous solu-
tion of the ELK1 (2 wt%, 18 µl) was slowly injec-
ted into the suspension of GO. The tip of the pipette
was allowed to contact the bottom of the well before
releasing the ELK1 solution vertically at a constant
speed. All samples were prepared in MilliQ water.
2.4. Diffusion-reaction of ELK1-GO tube wall
formation
The diffusion-reaction of ELK1-GO tube wall form-
ation is critical and determine the increase of tube
wall thickness over time. An imaging system was
used to observe tube formation and its behaviour
2
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Figure1. Rationale, assembly, and structure of the ELK1-GO bioink. (a) (1) The bioink assembles upon liquid-in-liquid printing
of an ELK1 (brown) solution comprising cells (green) into a solution of GO flakes (red), spontaneously triggering a
diffusion-reaction process at the solution interface and leading to the formation of a multi-layered membrane. (2) The process
enables trapping of cells within the membrane and immediate localization within the lumen of the resulting tubular structures.
(b) Scanning electron microscope (SEM) image of the cross-section of an ELK1-GO tubular structure depicting the resulting
multi-layered architecture. (c)–(e) SEM images of an ELK1-GO capillary with an internal diameter of∼10 µm and a tube wall
thickness of∼2 µm. (f) Time-lapse imaging of an∼1 mm diameter tube being perfused with a pulsatile (the pulse frequency was
1 Hz) flow at 12 ml min−1 depicting the change in tube diameter (white arrow) as a result of the material’s resilient properties.
(g) Time-lapse imaging of a 1 mm diameter tubular structure bent 180◦ and released.
over time. The system consisted of a Nikon cam-
era with a 1:1 macro lens, a mirror to reflect the
image on the lens of the camera and a light source
powered at 30 V (figure S1 (available online at
stacks.iop.org/BF/13/035027/mmedia)). A time lapse
was used to observe the membrane self-assembly.
2.5. Confocal microscopy
The interaction and localization of ELK1 and GO
was probed using laser scanning confocal and mul-
tiphoton microscopy (TCS SP2, Leica Microsystems,
Germany). ELK1 (2wt%)was dissolved in an aqueous
solution of Alexa Fluor™ 488 NHS Ester (10−6 wt%)
and GO were diluted to 0.1 wt% with an aqueous
solution of Rhodamine B (10−6 wt%). All solutions
were incubated for 20 min at 30 ◦C and protected
from light. Images were acquired at laser wavelengths
of 488 nm and 543 nm which correspond to the
excitation wavelength of Alexa Fluor and Rhodamine
B, respectively. Images were further processed using
ImageJ.
2.6. Scanning electronmicroscopy (SEM)
The microstructures of ELK1-GO membranes were
examined by SEM. ELK1-GO membranes were
dehydrated directly using increasing concentrations
of ethanol (20%, 50%, 70%, 90%, 96%, and 100%).
All samples were subjected to critical point drying
(K850, Quorum Technologies, UK) prior imaging.
The SEM micrographs were captured on Inspect F50
(FEI Comp, the Netherlands) after sputter-coating
with gold (10 nm thick). All samples consisting only
ELK1 or GOwere prepared for SEM imaging without
a prior cross-linking process.
2.7. 3D printing of ELK1-GOmaterials, perfusing,
and pulsating
A commercially available 3D printer (3D
DISCOVERY™, RegenHU, Switzerland) was applied
for the 3D printing of ELK1-GOmaterials. An 85 µm
diameter nozzle was used to release the solution of
the ELK1 (2 wt%) under 0.02–0.10 MPa pressure at
a range of speed between 10 and 100 mm s−1. The
printing nozzle was merged in a container with 0.1%
GO MilliQ water suspension. A peristaltic pulsat-
ile pump was used to perfuse 1 v/v green food dye in
MilliQ water. The perfusion speed was 12.5 mlmin−1
and the pulse frequency was 1 Hz.
2.8. Fabrication of capillary-based permeability
testing device
The device was produced by pouring a first base layer
of polydimethylsiloxane (PDMS) (1mm thickness) in
a Petri dish. After curing at 60 ◦C for 1 h, a metal
3
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needle of 0.8 mm outer diameter was placed on the
first layer and two pins for subsequent alignment of
the device. A second layer of PDMS was then poured
and cured in the Petri dish. The level of PDMS in
the second layer had to cover the needle. Petri dish
was then placed in an oven at 60 ◦C for 2 h to thor-
oughly cure both PDMS layers. Removal of tube with
forceps leaves a cylindrical cavity with a diameter of
0.8 mm. The PDMS with cavity was cut from centre
and divided into two chambers. A flat membrane
from an ELK1-GO tubular structure was inserted into
the middle of the device and divided the channels of
the left and right chambers. A test solution was injec-
ted into the right chamber, while the same solvent of
the test solution was injected into the left chamber
(figure S2(a)).
2.9. Permeability measurements
Two substances were used to measure permeability:
fluorescein sodium salt and FITC-dextran. These two
solutions were used to measure, respectively, the per-
meability of sodium ions and of macro molecules
(20 kDa and 40 kDa). MilliQ water (phosphate-
buffered saline) was injected into the left chamber
and a water solution of FITC-dextran or Fluorescein
sodium salt was added to the right chamber. The
concentration of GO for the formation of ELK1-GO
membranes was changed to observe the variations
of the permeability across the membrane. The GO
concentrations considered were: 0.05%, 0.10%, and
0.15%. An epi fluorescence microscope (Leica DMI
4000B, Epifluorescence Microscope with a LEICA
DFC 300FXCCD camera) was used to determine the
passage of molecules from one chamber of the device
to another one. Data collected from the intensity ana-










where V1 was the volume of the left chamber, C1 was
the concentration of molecules inside the left cham-
ber, V2 was the volume of the right chamber, C2 was
the concentration ofmolecules inside the right cham-
ber; L and A were the membrane thickness and area
respectively and D was the diffusion constant.
Then to determine the diffusion constant D, the
experimental data were fitted with an exponential






Once the diffusion constant D of the equation
(equation (2)) was determined, it was compared






The permeability constant (P) was calculated





where K is the partition constant, D is the diffusion
constant, and∆X is the thickness of the membrane.
2.10. Cell culture
GFP-Human umbilical vein endothelial cells (GFP-
hUVECs) (Fisher Scientific, Angio Proteomie GFP-
hUVECs, NC0601093, USA) were cultured in
EGM™-2Media (Lonza, CC-3156 andCC-4176). The
mediumwas changed every 3 d until the cells reached
80% confluency. GFP-hUVECs between passages 2
and 4 were used for experiments. The tubes were
first washed three times with PBS 8 h after assembly
and sterilized with UV for 45 min. Then each tube
was placed in a well of 48-well cell culture plate with
inner or outer side facing up. The EGM™-2 Media
(500 µl) containing different cell densities (5 × 103,
1 × 104, 5 × 104, and 1 × 105 ml−1) were added
to each well containing ELK1-GO membranes. The
coated wells were incubated for 8 h prior to cell seed-
ing. The cells were incubated at 37 ◦C and 5% CO2
for 48 h for permeability test (figure S2(b)).
2.11. Finite elements analysis
Finite elements method simulations were carried out
using COMSOL MultiPhysics® v5.5 software (license
number is N. 13075339). All the presented models
were developed using the Transfer of diluted species
module.
2.12. Permeability model
The aim of the first model was to identify the dif-
fusion coefficient of the membrane to dextran and
sodium salt starting from experimental data. A two-
dimensional (2D) axial symmetric transient model
was used. Different time points were set for dextran
(0 h,1 h, 3 h, 5 h) and sodium (0min, 20min, 40min,
60 min) according to experimental data previously
acquired. Themodel consists of three domains (figure
S3(a)). In each domain, transport properties are gov-
erned by the following balance equations (5) and (6):
∂Ci
∂t
+∇· Ji = Ri (5)
Ji =−Di∇Ci (6)
where Ci is the concentration (mol m−3), Di the dif-
fusion coefficient and Ri the reaction rate. Di = 1×
10−9m2 s−1 for domains 1 and 3 (same as water)
while it was considered as a parameter to be estim-
ated in the membrane (domain 2, parametric sweep
study). On the right side of themembrane (domain 1)
the initial concentration (t = 0 h min−1) of salt was
4
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1 M and 0.001 M for dextran and sodium, respect-
ively (C = 0 M for other domains). A transient
study allowed the evaluation of concentration pro-
file in the whole chamber across the membrane. All
external boundaries were set to no flux condition
(equation (7)).
− n · (Ji + uCi) = 0. (7)
For each image (acquired by epifluorescence micro-
scope), a normalized plot profile was obtained on the
centre line using ImageJ® software. The comparison
between the model and the real images was carried
out considering a single point in the left chamber
(1 mm from the left side) (figures S3(b) and (c)). The
normalized value of the grey level from the image was
compared with the normalized value of the concen-
tration in the same point of themodel at different dif-
fusion constants for each time point. Best fitting was
evaluated by calculating the adjusted R-squared para-
meter discarding values corresponding to the mem-
brane in both profiles (from 2 to 2.5 mm). Results are
shown in figure S4.
2.13. Reactionmodel
The aim of thismodel was to identify the time of reac-
tion between two species (aqueous solutions of 2 wt%
ELK1 in 0.1 wt% GO). A 1.6 mm radius ELK1 drop
in GO solution was simulated with a one-dimension
(1D) axial symmetric transient model. The model
consists of two domains: the first represents the ELK1
drop (initial value C2 = 0.4 mol m−3), while the
second is the GO solution (C1= 0.5molm−3) (figure
S3(d)). The two species will react creating a third C3
species. The transport properties of the species are
characterised by their diffusion constant in the differ-
ent domains. We made two hypotheses:
(a) Diffusion constant of ELK1 (C2) and GO (C1)
decreases linearly as C3 is formed according to
equation (8):







where D is the diffusion at generic instant t, Df is the
final value of diffusion constant with a stable mem-
brane, D0 is the starting diffusion constant before
the membrane formation, c is the concentration of
species C3 at generic instant t, cf is the concentra-
tion of the stable membrane. According to permeab-
ility model for dextran, the presence of the mem-
brane causes a diffusivity drop of at least three orders
of magnitude. We need to estimate concentration
at which the membrane can be considered stable.
Considering 1.5% ELK1, the protein is totally con-
sumed forming a stable membrane, with a resulting
concentration cf = 0.3 mol m−3. The starting
diffusion coefficient (D0) for proteins is about
10−9 m2 s−1, the final will be similar to that of
dextran (Df = 1× 10−12m2 s−1). The final value of
GO diffusion coefficient was estimated with a para-
metric simulation (Df = 1× 10−13, 1× 10−15, and
1× 10−17m2s−1; starting D0 for GO was considered
as typical values for large molecules 7× 10−11). On
the basis of these considerations, the diffusion con-
stant was modelled on COMSOL MultiPhysics® v5.5










< 0, reference dif-
fusion constant is Df.
(b) Diffusion of C3 is negligible (very low diffusion
constant DC3 = 1× 10−17m2 s−1).
A reaction was introduced in this model in both
domains. Reaction conditions were set as follows:
dC1/dt= Rc1 =−A(C1 ∗C2)
dC2/dt= Rc2 =−B [A(C1 ∗C2)]
dC3/dt= Rc3 = A(C1 ∗C2)
where A = reaction rate [m3 (mol · s)−1], B = stoi-
chiometric ratio ELK1:GO.
The previous equations assume that:
(a) reaction rate is 200 m3 (mol · s)−1;
(b) since stoichiometric ratio is ELK1:GO= 20:1,C2
decreases 20 times faster than C1;
(c) C3 increases as fast as C1 is consumed.
On the basis of these assumptions, the reactions were
modelled in COMSOL MultiPhysics® v5.5 with the
following equations:
RC1 =−200 ∗C1 ∗C2 ∗ (C1 > 0) ∗ (C2 > 0)
RC2 =−20 ∗ (200 ∗C1 ∗C2 ∗ (C1 > 0) ∗ (C2 > 0))
RC3 = 200 ∗C1 ∗C2 ∗ (C1 > 0) ∗ (C2 > 0)
where the expression [∗(C1 > 0) ∗ (C2 > 0)] means
that the reaction happens only if C1 and C2 are
present at the same time.
A transient study was computed over 800 s time
evaluating how C3 is formed at the interface between
C1 and C2 domains. In order to obtain a more accur-
ate solution a user-controlled mesh was introduced
by setting the maximum element size to 0.005 mm.
Results are shown in figure S5.
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2.14. Gradient model
The aim of this model was to identify the gradi-
ent concentration trend over time of three different
GO solutions placed in a 6 cm diameter Petri dish.
The three solution were 0.05%, 0.10%, and 0.15%
GO w/v respectively, corresponding to 0.25, 0.5 and
0.75 mol m−3 (MW of GO is 2043.8 g mol−1). A
2D transient model consisting of four domains was
developed: domain 1 corresponds to water, while 2, 3
and 4 are the three different GO solutions placed with
increasing concentration value (figure S3(e)). Diffu-
sion constant was set to Di = 1× 10−9m2 s−1 (same
as water). Concentration trend over a 96 h time was
evaluated on a cut line placed in the middle of the
Petri dish (red line in figure S3(e)).
3. Results and discussion
3.1. Rationale of the study
Our previous research demonstrated that, upon
printing a solution of ELK1 into another of GO
(figure 1(a)), hydrophobic and electrostatic interac-
tions trigger ELK1-GO co-assembly and an interfacial
diffusion-reaction process that gives rise to a multi-
layered membrane (figure 1(b)). In the current work,
we study inmore detail the diffusion-reaction process
to better control the ELK1-GO co-assembly, forma-
tion of the tubular structure, and the properties of
the interfacial membrane including thickness, poros-
ity, and permeability. Bymodulating the way in which
both solutions are mixed, it is possible to spatially
control this process and generate hierarchical tubular
structures by integrating bottom-up assembly with
top-downmanufacturing. Furthermore, by standard-
izing together both the printing and co-assembling
parameters, the system enables control over the print-
ability, shape fidelity, and ultimate feature resolution
(i.e. tube diameter and tube wall thickness) of the
bioink. Through this approach, the resulting mater-
ial (i.e. tube wall) can be designed to exhibit a variety
of physiologically-relevant properties such as tune-
able thickness (down to ∼2 µm), stiffness, permeab-
ility, and the ability to be robust and compliant, evid-
enced by the capacity to pulsate under physiological
fluid flow (i.e. shear stress of ∼0.26 N m−2, which
is within the range of that present in carotid arteries
[30]) (figure 1(f) and movie S1) and be bent without
displaying any kinks (figure 1(g) andmovie S2). Con-
sequently, we first conducted experiments and simu-
lations to characterize, standardize, and optimize the
printing parameters.We then focused on further con-
trolling the printing fidelity and material properties
by modulating the concentration of GO. Given the
potential use of the bioink to fabricate perfusable flu-
idic systems and structures that can recreate biolo-
gical ones, we then conducted a thorough characteriz-
ation of tube wall permeability with and without cells
as well as developed ways to fabricate structures with
tuneable and anisotropic permeability.
3.2. Standardization and optimization of the
printing process
Standardization and optimization experiments were
conducted by integrating top-down (3D printing)
and bottom-up (self-assembly) fabrication paramet-
ers tomaximize printing fidelity and control over res-
ulting geometric features.
3.2.1. ELK1-GO diffusion-reaction process and
printing fidelity
We conducted experiments and simulations to char-
acterize bioink shape fidelity as determined by the
diffusion-reaction mechanism triggered upon ELK1-
in-GO printing. First, an 18 µl aqueous solution of
ELK1 (2 wt%) was manually injected into an aqueous
suspension of GO (0.10 wt%, 100 µl) in a 96-well
plate to generate a vertical tube. The processwas video
recorded (figure S1) and imaged at different time-
points to investigate the kinetics of tube wall forma-
tion (figure 2(a)) and movie S2). Separately, a ‘trans-
port of diluted species’ COMSOL model simulating
similar experimental conditions was generated and
used to validate the experimental results. Both experi-
mental and simulation results were in agreement and
revealed that the ELK1-GO tube exhibited a similar
diameter as that of the starting ELK1 injected drop
and the ELK1-GO tubewall thickness did not increase
after ∼60 s of interaction (figure 2(a), figure S5).
These results demonstrate that the initial volume of
the ELK1 injection determined the outside dimen-
sion of the final printed structure (figure 2(a)) and
that this dimension was not affected by the growth
of the ELK1-GO interfacial tube wall as a result of its
diffusion-reaction process.
3.2.2. Tuneable geometry by varying printing
parameters and GO concentration
The printability of the ELK1-GO bioink was charac-
terized using a commercially available 3D printer (3D
Discovery™, RegenHU, Switzerland) with adjustable
nozzle heights and diameters, dispensing pressures,
and printing speeds [31]. By fixing nozzle height and
diameter, we assessed the relation between dispensing
pressure and printing speed. The fidelity of fabricated
ELK1-GO tubes was assessed by optically and system-
atically measuring tube diameters at different loca-
tions [32], which revealed increased printing fidel-
ity with increasing printing speed (figures 2(b) and
(c)). Larger diameter differences within a single tube
led to larger variances, which resulted in rugged tube
walls (figure 2(b), printing speed: 10 mm s−1). By
varying the dispensing pressure of the ELK1 solution
between 0.02 and 0.10 MPa and the printing speed
(PS) between 10 and 100 mm s−1 (nozzle height and
diameter were fixed, figure 2(b), table), we found
that tubes were generated when the dispensing pres-
sure was between 0.04 and 0.08 MPa. When printing
within this pressure range and printing speeds above
30 mm s−1, variances in tube wall geometry within a
6
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Figure 2. Diffusion-reaction process and printing fidelity. (a) Time-lapse optical images of a co-assembling tube upon immersion
of a solution of ELK1 into a solution of GO depicting a growing tube wall (shown between white arrows) reaching a maximum of
∼150 µm in thickness after∼60 s. In the bottom row, corresponding images of tube wall thickness from ‘transport of diluted
species’ COMSOL model simulations (rainbow colour) confirming the increasing thickness of the tube wall as a result of the
time-dependent diffusion-reaction process of formation. (b) The graph on the left reports on the relationship between printing
speed, releasing pressure, and fabricated tube diameters. Error bars represent±SD for n= 10. ∗p < 0.05. t test. The images on the
right illustrate the printing fidelity of the ELK1-GO bioink in relation to different printing parameters. (c) Confocal image of a
longitudinal-section of an ELK1-GO depicting the tube walls (between white arrows) (green= ELK1, red= GO) demonstrating
a high-fidelity tubular structure. (d). Graphs and €. Corresponding confocal images of unilateral longitudinal-sections of the wall
of ELK1-GO tubes revealing the relationship between the concentration of the GO suspension prior to co-assembly and the
resulting tube wall thickness.±SD for n= 5. ∗p < 0.05. t test.
single tube were under 5%, which reflected high fidel-
ity tubes with smooth walls (figure 2(b)). Utilizing a
dispensing pressure of 0.06 MPa and printing speed
of 30 mm s−1, we were able to print tubes of up to
12 cm in length and 2mm in diameter. It is important
to mention, however, that the limitation on tube
length was not lack of tube integrity but rather the
size of the plate used to hold the GO solution during
printing.
Printing fidelity was also characterized by varying
the concentration of the GO suspension (figure 2(c)).
In this case, lower concentrations of GO (0.05 wt%)
7
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generated tubes with lower printing fidelity and
thinner tube walls (∼40 µm), while higher GO
concentrations (0.10 and 0.15 wt%) resulted in
tubes with higher printing fidelity and thicker walls
(∼60 µm) (figures 2(d) and (e)). We speculate that
this difference in wall thickness results from interfa-
cial membranes forming with varying levels of per-
meability as a result of having different concen-
trations of GO. We have demonstrated that upon
initial ELK1-GO co-assembly, a diffusion barrier is
formed, which defines its downstream diffusion-
reaction mechanism that generates the distinctive
multilayermembrane [29].We reason that lower con-
centration of GO (0.05 wt%) leads to a more per-
meable diffusion barrier, which allows for higher
and faster ELK1 diffusion and consequently thinner
multi-layered membranes. In contrast, higher con-
centration of GO (0.15 wt%) upon co-assembly res-
ults in the formation of a less permeable diffusion bar-
rier, which results in thicker membranes.
3.2.3. Tuneable porosity by varying the concentration
of GO suspension
Having characterized printing reproducibility and
fidelity, we then focused on exploiting the co-
assembling nature of the bioink to control ELK1-GO
tube wall porosity by varying the concentration of
GO. Tubes were first co-assembled with varying GO
concentrations (0.05 wt%, 0.10 wt%, and 0.15 wt%)
and cut to extract flat membranes (the tube wall)
(figure S1(a)). The luminal (inner) and abluminal
(outer) sides of thesemembranes were then examined
by SEM following standard preparation protocols
[29]. As expected, increased GO concentrations led
to decreased porosity, which was easily noticeable
on both inner and outer surfaces of the membranes
(figure 3(a)). Upon closer inspection, significant dif-
ferences in porosity between the inner and outer sur-
faces were observed on all membranes, independently
of GO concentration (figure 3(b)), which was also
confirmed by histological sectioning (figure 3(d)).
These results demonstrated the possibility to mod-
ulate the ELK1-GO tube wall pore sizes from 0.5
to 1.2 µm on the inner surface and 1.6–4.0 µm
on the outer one by modifying GO concentrations
(figure 3(c)).
Together with the previous results of printing
fidelity and tuneability of geometry and porosity,
we can conclude that higher GO concentration and
printing speed (50 mm s−1 < PS < 70 mm s−1)
can be used to fabricate higher fidelity tubes with
smooth and thicker (∼60 µm) fully formed tube
walls but less porosity after 60 s of co-assembly.
By contrast, lower GO concentration and printing
speed (30 mm s−1 < PS < 50 mm s−1) would
generate lower fidelity tubes with rugged and thin-
ner (∼40 µm) tube walls exhibiting higher levels of
porosity. Importantly, upon ELK1-GO co-assembly,
the thickness of the resulting interfacial structures
depends on the time-dependent diffusion-reaction
process of formation (figure 2(a)). Consequently,
given the high ELK1-GO affinity, it is possible to stop
the co-assembly process at different time points, res-
ulting in interfacial membranes of different thick-
nesses. We found that it was possible to stop the co-
assembly process after just 15 s by removing the fab-
ricated tube from the GO suspension, resulting in
tube wall thicknesses down to ∼2 µm when print-
ing at >70 mm s−1. Furthermore, tube wall thick-
nesses were observed to reach amaximumof ∼20µm
in thickness (figure 2(c)) after ∼60 s of co-assembly,
which did not seem to change after longer periods
of time. We speculate that these thin tube walls res-
ult from the low ELK1 volumes released upon print-
ing at fast printing speeds (>70 mm s−1), offering
an opportunity to reproducibly fabricate with resol-
utions down to a few microns in size (figures 1(c)
and (d)). In summary, these results demonstrate
how bioprinting fidelity and resolution can be tuned
through both printing parameters from the top-down
and self-assembling events taking place from the
bottom-up.
3.3. Assessment of applicability
After standardization of fabrication parameters, we
then focused on demonstrating applicability and key
advantages of the bioink including the capacity to
tailor permeability, display pulsatility, and fabricate
structures exhibiting anisotropic permeability.
3.3.1. Tuneable permeability by varying porosity
The possibility to control tube wall porosity opens
an opportunity to fabricate membranes, capillaries,
and other structures with tuneable permeability that
could be designed to recreate that of biological tissues.
For example, proper vascular permeability is of out-
most importance inmany biological processes such as
regulating diffusion of nutrients and waste products,
serving as a semipermeable barrier between blood
contents and tissues to screen toxic molecules, and
regulating the microenvironment of the ECM [33].
Furthermore, diffusion across vascular and lymphatic
tissues is vital to enable appropriate filtration, pro-
tection, and delivery of key solutes, cells, and factors.
The capacity to develop vascular structures or fluidic
devices with tuneable permeability is critical to recre-
ate and optimize biofunctionality. To assess the effect
of tube wall porosity on its permeability, we designed
a simple capillary-based permeability testing device
where the membrane (cut from the ELK1-GO tube)
can be positioned in the middle, leaving two free
chambers on either side (figure S2(a)). The chambers
can be filled with any solution, enabling diffusion of
solutes from one side to the other (figure S2(a)). We
tested the permeability of the membrane to fluores-
cein sodium salt and 20 kDa FITC-dextran in water
solution to recreate physiological charge and size
8
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Figure 3. Control of tube wall porosity by varying the concentration of GO. (a). SEM images and b, c corresponding
quantifications of porosity (b) and pore size, (c) demonstrating significant differences in porosity between the inner and outer
surfaces on all membranes (tube walls) and pore sizes by modifying GO concentration. (d) Histological slide of tube wall
cross-section demonstrating the decrease in porosity from the inner side of the tube wall to the outer side of the tube wall.±SD
for n= 3. ∗p < 0.05. t test.
barriers, respectively. These two functions are nor-
mally observed in vascular tissue [33]. Using epifluor-
escence microscopy imaging, permeability constants
were calculated based on the fluorescence intensity
profiles recorded on the chamber where the solutes
diffused to (figure 4(a)). Specifically, exponential
curves describing the trend of the average intens-
ity within the chamber as a function of time were
calculated for each ELK1-GO membrane and the
permeability constant measured based on a diffusion
constant using a fitting plot [34] (figure 4(b)).
To confirm these results, we established a ‘trans-
port of diluted species’ COMSOL model to predict
the permeability of sodium salt through the mem-
brane (figure 4(a)). Similar to the experimental setup,
sodium salt exhibited faster diffusion than 20 kDa
FITC-dextran (figure 4(c)) with a permeability
constant of ∼5 × 10−5 cm s−1. Furthermore, as
expected, we found that the permeability constants
decreased with increasing concentration of GO for
both fluorescein sodium salt (from 1 × 10−5 cm s−1
to 5 × 10−5 cm s−1) and 20 kDa FITC-dextran
9
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Figure 4. Control of tube wall permeability by varying the concentration of GO. (a) Confocal images and corresponding
‘transport of diluted species’ COMSOL model simulations of a perfused ELK1-GO membrane (cut from an ELK1-GO tube)
positioned in the middle of a capillary-based permeability testing device. Upon injection of fluorescein sodium salt solution in the
right chamber, progressive diffusion across the membrane is observed at different time points in the left chamber. In the bottom,
red colour indicating high fluorescein sodium salt concentration while green colour indicating low concentration. (b) Graphs
depicting the time-dependent fluorescein density change of FITC-dextran 20 kDa (left) and fluorescein sodium salt (right) in the
left chamber of the permeability testing device with fitting lines. (c) Permeability constants calculated based on the data reported
in (b) revealing the permeabilities of ELK1-GO membranes for FITC-dextran 20 kDa and fluorescein sodium salt decrease with
the increasing concentration of GO suspension.
(from 2 × 10−6 cm s−1 to 58 × 10−6 cm s−1)
(figure 4(c)).
These results demonstrate the potential of
the ELK1-GO bioink to fabricate membranous
and tubular structures while enabling regulation
of permeability. By simply modulating GO con-
centration, it is possible to fabricate complex
structures made from thin membranes with per-
meability constants comparable to those of the
native retina (∼2× 10−5 cm s−1) [35], lymphatic-
vessels (∼6.4× 10−6cm s−1) [36], an hUVEC-
containing Transwell (∼5 × 10−6 cm s−1) [37], and
organ-on-chip devices of the blood-brain-barrier
(∼5× 10−5 cm s−1) [38].
3.3.2. Tuneable permeability after endothelialisation
In our previous study, we demonstrated how
the ELK1-GO self-assembling system can be
incorporated within liquid-in-liquid printing to
biofabricate tubular structures comprising cells
exhibiting high viability and growth for at least 7 d
[29]. To demonstrate the functionality and biolo-
gical relevance of the bioink, we conducted similar
permeability tests but after endothelialisation of the
lumen of the ELK1-GO tubes. This setup enabled
us to better account for the localization of the cells
and their effect on tube-wall permeability. Different
densities (5× 103, 1× 104, 5× 104, or 1× 105 ml−1)
of hUVECs were seeded on the luminal side of
membranes (cut from ELK1-GO tubes) (0.10 wt%
GO) placed on Petri dishes (figure S2(b), top). We
chose the method of seeding hUVECs after tube
formation instead of directly co-assembling with
cells to more precisely account for the localization
of the cells, their interaction, and the resulting effect
on permeability. As expected, after 48 h of culture,
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Figure 5.Modification of permeability after endothelialisation. (a) Confocal images of hUVECs (green) grown at different
confluency levels (left to right: 30%, 50%, 80%, >95%) on the inner side of ELK1-GO membranes. (b) Graphs recording the
fluorescein density change of FITC-dextran 40 kDa with time in the left chamber with fitting lines and (c). Permeability constants
calculated based on the data reported in (b) for FITC-dextran 40 kDa permeability through ELK1-GO-hUVECs membranes.
Membrane permeability tended to decrease with increased cell density, with membranes without cells (control) exhibiting the
highest permeability constant while those with the highest cell density exhibiting the lowest one.±SD for n= 3. ∗p < 0.05. t test.
membranes exhibited different hUVEC densities
including∼30%, 50%, 80%, and >95%, as measured
by confocal microscopy imaging (figure 5(a), con-
focal images). Then, these membranes were inserted
into the permeability test device with hUVECs facing
one of the chambers (figure S2(b), bottom). Then,
40 kDa FITC-dextran [39] in phosphate-buffered
saline (PBS) was flowed into the chamber facing
the cells while PBS alone was flowed into the other.
Here, we used 40 kDa FITC-dextran instead of the
20 kDa FITC-dextran as it is widely used to test bio-
material permeability [39]. The results demonstrated
that membrane permeability tended to decrease with
increased cell density, with membranes without cells
(control) exhibiting the highest permeability constant
(2.2 × 10−6 cm s−1) while those with the highest
cell density exhibited the lowest permeability con-
stant (6.5 × 10−7 cm s−1) (figures 5(b) and (c)).
In conclusion, the presence of hUVECs growing on
the ELK1-GO tube wall significantly influenced the
transport of solutes in a way that is dependent on the
level of hUVEC confluency. We speculate that lower
cell densities led to lower number of endothelial cell
junctions, which in turn led to higher permeabilit-
ies. These results further support the possibility to
tune structure permeability and, in particular, to do
it through the presence of cells. For example, the per-
meability constant of ELK1-GO-hUVECmembranes
(∼1 × 10−6 cm s−1) with confluence levels above
50% were comparable with that of tumour micro
vessels (1.8× 10−6 cm s−1) [40].
The possibility to rapidly and controllably engin-
eer living capillary- and vascular-like structures
remains a major unmet challenge in biofabrication,
tissue engineering, and in vitro models. Feng et al
have demonstrated how liquid-in-liquid printing can
be used to fabricate perfusable tubular structures
[24] but the system relies on aqueous nanoclay
dispersions and solutions of H2N-PDMS-NH2 in
toluene, which prevents the use of cells and recre-
ation of key anatomical and physiological features.
On the other hand, perfusable channels within bulk
gel structures have been reported by Skylar-Scott et al
[41], but these structures fail to recapitulate capillary
features such as an outside surface and thin wall
thicknesses, which consequently affect biomechanics
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Figure 6. Fabrication of tubular structures with anisotropic porosity and permeability. (a) Images of ‘transport of diluted species’
COMSOL model simulations and corresponding graphs demonstrating the maintained gradient of increasing GO concentration
in solution for at least 3 h. (b) Illustration of the mechanism of fabricating the tubular structures with progressively decreasing
porosity and permeability by printing the ELK1 solution from right to left into the GO solutions. (c) Schematic of the fabrication
process and mechanism of assembly of a tubular structure with progressively increasing concentration of GO. GO was stained
with Rhodamin B (red, middle image) prior to printing of the ELK1 solution to enable GO visualization within the tube wall.
After ELK1-GO tube fabrication, FITC-dextran 20 kDa (green, bottom image) was perfused through the tube and was observed
to diffuse in time through the tube wall with higher levels of diffusion in the areas of the tube with lower concentration of GO
(qualitatively increasing diffusion from left to right). (d) Optical microscope image and time-lapse confocal images of the
perfused tube with FITC-dextran 20 kDa (green) at different times points. A fluorescent intensity analysis on the permeated area
outside the tube (X axis= parallel to the tube axis, Y axis= perpendicular to the tube axis) confirming the anisotropic
permeability variance at different time points.
and diffusion kinetics. Our system aims to overcome
some of these challenges by providing a facile way to
manufacture biohybrid capillary-like structures with
physiological properties.
3.3.3. Fabrication of tubular structure with anisotropic
porosity and permeability
To further demonstrate the potential of the self-
assembling ELK1-GO bioink for the biofabrication
of complex structures with innovative properties, we
printed tubes but now exhibiting different porosit-
ies and corresponding permeabilities within the same
structure along the tube axis (figure 6(c), illustrator).
These types of structures are observed in biological
systems such as renal tubules [42] and arterioven-
ous networks [43]. To our knowledge, these structures
have not been fabricated in a single printing process.
We first designed an experimental setup that enabled
12
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the formation of a MilliQ water solution made with
different concentrations of GO contiguously increas-
ing from 0.15 wt% on the left side, 0.10 wt% on the
middle, and 0.05 wt% on the right side (figure 6(a)).
The GO was stained with Rhodamin B prior to print-
ing of the ELK1 to enable GO visualization in the
tube wall. In this setup, we found that the gradient
of the GO in solution was maintained for at least
3 h, which was confirmed by a ‘transport of diluted
species’ COMSOL model (figure 6(a)) and facilitated
the printing process. Upon extrusion of the ELK1
solution into the GO solution from the lower to the
higher concentration of GO, the tube formed imme-
diately at the interface of both liquids with the tube
wall progressively assemblingwith increasing concen-
trations of GO (figure 6(b)). The resulting tubular
structure was then characterized via epifluorescence
microscopy, which revealed a tube wall with increas-
ing content of GO and consequently a porosity gradi-
ent (figure 6(c), red). To test the effect of this poros-
ity gradient on the permeability of the overall tube,
20 kDa FITC-dextran solution was perfused through
and, as expected, its diffusion progressively decrease
along the tube direction as the GO concentration
increased (figures 6(c), green and (d)). These kinds
of anisotropic structures are prevalent in biological
systems such as in renal tubules [42] and arterioven-
ous networks [43]. Our bioink enables the fabrication
of such anisotropic vascular structures in a simple
manner.
4. Conclusion
Self-assembling bioinks offer unique opportunities to
the field of biofabrication. However, it is essential
to establish reproducible processes, optimize printing
parameters, and demonstrate their ability to fabricate
novel structures with anatomical and physiological
relevance. Here, we have standardized and optim-
ized a multicomponent self-assembling bioink and
demonstrated its potential to biofabricate structures
with innovative properties. Through experimental
work and simulations, we have confirmed the pos-
sibility to use the ELK1-GO bioink to fabricate a
single tubular structure with hierarchical organiz-
ation and resolutions down to ∼10 µm in dia-
meter made with ∼2 µm thick walls. These struc-
tures enable immediate perfusion after assembly and
exhibit physical properties such as stiffnesses and the
capacity to pulsate that resemble physiological struc-
tures. In addition, the bioink permits printing fidel-
ity and control over structure porosity and permeab-
ility by modulating the concentration of GO and the
possibility to guide this process to fabricate structures
with permeability gradients. Furthermore, the bioink
is biocompatible and facilitates hUVEC bioprinting,
growth, and proper function, enabling further con-
trol of permeability. However, to fully exploit these
advantages, it is of outmost importance to incor-
porate the printing/self-assembling processing and
structures reported here within functional devices
such as tissue engineered constructs or organ-on-
chip devices. Nonetheless, the current work moves us
a step closer towards the scalable manufacturing of
structurally complex capillary-based constructs that
can be designed to recreate the structural and per-
meability properties of native tissues within engin-
eered devices.
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